Well that's your view from one angle, but looking at the healing...

Well that's your view from one angle, but looking at the healing improvement rate, once it gets into the phase 3, am pretty confident we won't be able to catch it without paying more than double, remember its not a radio pharmaceutical, T-cell or brain cell recovery trial thing that runs for ages due to restrictions like one patient at a time dozing.. TRP is just wound healing much visible to naked eyes, and all physicians and support staff will easily spot the difference.. considering the first check point is in just 4 weeks once the group is treated, I reckon it turns out to be a high potential takeover candidate by end of 2023 assuming trial begins at Q4 this year as planned. lets see which one plays out well 22cents now or later during trial. Cheers